Trials / Completed
CompletedNCT00542295
Efficacy and Safety of Meteospasmyl® in Irritable Bowel Syndrome
Efficacy and Safety of Meteospasmyl® in Irritable Bowel Syndrome. a 4-Week, Multicentre, Double-Blind, Randomised, Placebo-Controlled Phase IV Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- Sponsor
- Laboratoires Mayoly Spindler · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To assess the effectiveness of alverine citrate and simeticone on IBS symptoms according to the latest recommended design
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | alverine citrate and simeticone | |
| DRUG | placebo |
Timeline
- Start date
- 2007-07-01
- Primary completion
- 2008-07-01
- Completion
- 2008-09-01
- First posted
- 2007-10-11
- Last updated
- 2008-10-01
Locations
18 sites across 2 countries: Hungary, Poland
Source: ClinicalTrials.gov record NCT00542295. Inclusion in this directory is not an endorsement.